Skip to content
naulon

Not checkedNot checked for notices yet.

<it>In vivo </it>activity of terpinen-4-ol, the main bioactive component of <it>Melaleuca alternifolia </it>Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic <it>Candida </it>species

Cassone Antonio, Girolamo Antonietta, De Bernardis Flavia and 2 more

BMC Infectious Diseases · 2006

doi:10.1186/1471-2334-6-158 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>Recent investigations on the antifungal properties of essential oil of <it>Melaleuca alternifolia </it>Cheel (Tea Tree Oil, TTO) have been performed with reference to the treatment of vaginal candidiasis. However, there is a lack of <it>in vivo </it>data supporting <it>in vitro </it>results, especially regarding the antifungal properties of TTO constituents. Thus, the aim of our study was to investigate the <it>in vitro </it>and the <it>in vivo </it>anti-<it>Candida </it>activity of two critical bioactive constituents of TTO, terpinen-4-ol and 1,8-cineole.</p> <p>Methods</p> <p>Oophorectomized, pseudoestrus rats under estrogen treatment were used for experimental vaginal infection with azole (fluconazole, itraconazole) -susceptible or -resistant strains of <it>C. albicans</it>. All these strains were preliminarily tested for <it>in vitro </it>susceptibility to TTO, terpinen-4-ol and 1,8-cineole for their antifungal properties, using a modification of the CLSI (formerly NCCLS) reference M27-A2 broth micro-dilution method.</p> <p>Results</p> <p><it>In vitro </it>minimal inhibitory concentrations (MIC<sub>90</sub>) values were 0.06% (volume/volume) for terpinen-4-ol and 4% (volume/volume) for 1,8-cineole, regardless of susceptibility or resistance of the strains to fluconazole and itraconazole. Fungicidal concentrations of terpinen-4-ol were equivalent to the candidastatic activity. In the rat vaginal infection model, terpinen-4-ol was as active as TTO in accelerating clearance from the vagina of all <it>Candida </it>strains examined.</p> <p>Conclusion</p> <p>Our data suggest that terpinen-4-ol is a likely mediator of the <it>in vitro </it>and <it>in vivo </it>activity of TTO. This is the first <it>in vivo </it>demonstration that terpinen-4-ol could control <it>C. albicans </it>vaginal infections. The purified compound holds promise for the treatment of vaginal candidiasis, and particularly the azole-resistant forms.</p>

Abstract licence: CC BY-NC-ND

Cited by papers we hold2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.